Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. QNCX
QNCX logo

QNCX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

QNCX News

Quince Therapeutics Settles Debt Obligations, Shares Rise

Mar 30 2026NASDAQ.COM

Quince Therapeutics Settles Debt to Enhance Strategic Flexibility

Mar 30 2026seekingalpha

Quince Therapeutics Shares Surge 40% After Debt Settlement Announcement

Mar 30 2026stocktwits

Quince Therapeutics Settles Debt Obligations with EIB

Mar 30 2026Newsfilter

Quince Therapeutics Resolves EIB Loan Responsibilities for $5.5 Million, According to SEC Filing

Mar 30 2026moomoo

Quince Therapeutics Shares Surge After Hours Despite Major Losses

Feb 13 2026Benzinga

Quince Therapeutics Stock Plummets 52% Amid Financial Struggles

Feb 12 2026Benzinga

U.S. Stocks Mostly Higher in Morning Trade, Dow Up Over 200 Points

Feb 12 2026Benzinga

QNCX Events

04/16 08:50
VisionWave Holdings Borrow Rate Increases to 74.93%
Latest data shows the largest indicative borrow rate increases among liquid option names include: VisionWave Holdings Inc (VWAV) 74.93% +7.23, Merlin Inc (MRLN) 76.60% +2.56, Quince Therapeutics (QNCX) 102.41% +1.54, Alto Ingredients (ALTO) 2.41% +1.38, Rumble (RUM) 9.50% +1.31, WeRide Inc (ADR) (WRD) 1.84% +1.09, Teucrium Sugar Fund (CANE) 1.22% +0.97, Leverage Shares 2X Long NBIS Daily ETF (NBIG) 5.06% +0.69, iShares MSCI India (INDA) 6.05% +0.54, and Defiance Daily Target 2X Long RGTI ETF (RGTX) 28.47% +0.49.
04/10 08:50
Significant Increases in Borrow Rates Among Liquid Option Names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Cracker Barrel (CBRL) 7.79% +3.06, Quince Therapeutics (QNCX) 101.55% +2.58, ProShares Ultra (BOIL) 4.88% +1.25, Banco Bradesco (BBD) 12.81% +1.03, Direxion Daily 20 plus Year Treasury Bear 3X Shares (TMV) 39.06% +0.95, Beyond Meat (BYND) 28.93% +0.60, Defiance 1.75x MSTR ETF (MSTX) 28.55% +0.58, Canopy Growth (CGC) 24.20% +0.57, Powershares Loan ETF (BKLN) 3.54% +0.53, and DIREXION DAILY GOOGL BULL 1.5X SHARES ETF (GGLL) 6.73% +0.50.
03/30 08:40
Quince Therapeutics Settles $16.4M Debt
Quince Therapeutics announced the settlement of the company's outstanding obligations under its loan from the European Investment Bank for a payment of $5.5M. Effective immediately upon the $5.5M payment, Quince settled outstanding EIB debt obligations of approximately $16.4M as of March 27. As a direct result of this $5.5M payment, all of the company's obligations under both the settlement agreement and the underlying loan agreement have been fully satisfied and discharged.

QNCX Monitor News

Quince Therapeutics Inc stock rises after crossing above SMA

Apr 16 2026

Quince Therapeutics stock rises after crossing above SMA

Apr 10 2026

Quince Therapeutics Inc stock drops significantly

Apr 09 2026

Quince Therapeutics settles debt obligations, enhancing financial flexibility

Apr 06 2026

Quince Therapeutics Settles Debt, Enhances Strategic Flexibility

Apr 02 2026

Quince Therapeutics Settles Debt, Enhances Strategic Flexibility

Mar 31 2026

Quince Therapeutics stock surges amid market gains

Mar 30 2026

Quince Therapeutics Inc stock rises amid market gains

Mar 25 2026

QNCX Earnings Analysis

No Data

No Data

People Also Watch